Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer

International Journal of Cancer

Volumn 74, Issue 1, 1997, Pages 50-56

  Vernon, Suzanne D ^a,c   Unger, Elizabeth R ^b   Miller, Donna L ^a   Lee, Daisy R ^b   Reeves, William C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA INTEGRATION; FEMALE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER; VIRUS GENE;

EID: 0030965944     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19970220)74:1<50::aid-ijc9>3.0.co;2-%23     Document Type: Article

References (27)

1. BAKER, C.C., PHELPS, W.C., LINDGREN, V., BRAUN, M.J., GONDA, M.A. and HOWLEY, P.M., Structural and transcriptional analysis of human papillomavirus 16 sequences in cervical carcinoma cell lines. J. Virol., 61, 962-971 (1987).
2. BERUMEN, J., CASAS, L., SEGURA, E., AMEZCUA, J.L. and GARCIA-CARRANCA, A., Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int. J. Cancer, 56, 1-6 (1994).
3. BERUMEN, J., UNGER, E.R., CASAS, L. and FIGUEROA, P., Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum. Pathol., 26, 676-681 (1995).
4. CHUO, K.B., PAN, H.C. and HAN, S.H., Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology, 161, 259-261 (1987).
5. COOPER, K., HERRINGTON, C.S., STICKLAND, J.E., EVANS, M.F. and MCGEE, J.O., Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J. clin. Pathol., 44, 990-996 (1991).
6. CULLEN, A.P., REID, R., CAMPION, M. and LÖRINCZ, A.T., Analysis of physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J. Virol., 65, 606-612 (1991).
7. DAS, B.C., SHARMA, J.K., LUTHRA, G.K. and LUTHRA, G., Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. gen. Virol., 73, 2327-2336 (1992).
8. DOWHANICK, J.J., MCBRIDE, A.A. and HOWLEY, P.M., Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69, 7791-7799 (1995).
9. JEON, S., ALLEN-HOFFMANN, B.L. and LAMBERT, P.P., Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol., 69, 2989-2997 (1995).
10. JEON, S. and LAMBERT, P.F., Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. nat. Acad. Sci. (Wash.), 92, 1654-1658 (1995).
11. KAPLAN, E.L. and MEIER, P., Nonparametric estimates from incomplete observations. J. Amer. Stat. Ass., 53, 457-481 (1958).
12. KRISTIANSEN, E., JENKINS, A. and HOLM, R., Coexistence of episomal and integrated HPV 16 DNA in squamous cell carcinoma of the cervix. J. clin. Pathol., 47, 253-256 (1994).
13. LEHTINEN, M., LEMINEN, A., KUOPPALA, T., TIIKKAINEN, M., LEHTININ, T., LEHTOVIRTA, P., PUNNONEN, R., VESTERINEN, E. and PAAVAONEN, J., Pre-and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma. J. med. Virol., 37, 180-186 (1992).
14. LENNER, P., DILLNER, J., WIKLUND, F., HALLMANS, G. and STENDAHL, U., Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix. Cancer Immunol. Immunother., 40, 201-205 (1995).
15. MATSUKURA, T., KOI, S. and SUGASE, M., Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology. 17, 63-72 (1989).
16. MEHTA, C.R. and PATEL, N.R., A network algorithm for performing Fisher's exact test in r X c contingency tables. J. Amer. Stat. Ass., 78, 427-434 (1983).
17. ROMANCZUK, H. and HOWLEY, P.M., Disruption of either the E1 or the E2 regulatory genes of human papillomavirus type 16 increases viral immortalization capacity. Proc. nat. Acad. Sci. (Wash.), 89, 3159-3163 (1992).
18. ROSL, F., ARAB, A., KLEVENZ, B. and ZUR HAUSEN, H., The effect of DNA methylation on gene regulation of human papillomaviruses. J. gen. Virol., 74, 791-801 (1993).
19. SANG, B.C. and BARBOSA, M.S., Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events. Virology, 189, 448-455 (1992).
20. SHIRASAWA, H., TOMITA, Y., FUSE, A., YAMAMOTO, T., TANZAWA, H., SEKIYA, S., TAKAMIZAWA, H. and SIMIZU, B., Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. J. gen. Virol., 70, 1913-1919 (1989).
21. SHIRASAWA, H., TOMITA, Y., KUBOTA, K., KASAI, T., SEKIYA, S., TAKAMIZAWA, H. and SIMIZU, B., Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J. Virol., 62, 1022-1027 (1988).
22. THOMS, W.W., UNGER, E.R., JOHNSON, P.R., SPANN, C.O., HUNTER, S.H., SMITH, R., HOROWITZ, I.R., ICENOGLE, J.P., VERNON, S.D. and REEVES, W.C., Survival of women with cervical at Grady Hospital, Atlanta. Cancer, 76, 2518-2523 (1995).
23. TUREK, L.P., The structure, function and regulation of papillomaviral genes in infection and cervical cancer. Adv. Virus Res., 44, 305-356 (1994).
24. UNGER, E.R., BRIGATI, D.J., CHENGISS, M.L., BUDGEON, L.R., KOEBLER, D., CUOMO, C. and KENNEDY, T., Automation of in situ hybridization: application of the capillary action robotic workstation. J. Histotechnol., 11, 253-258 (1988).
25. 35S and biotin as labels for in situ hybridization: use of an HPV model system. J. Histochem. Cytochem., 39, 145-150 (1991).
26. UNGER, E.R., VERNON, S.D., THOMS, W.W., NISENBAUM, R., SPANN, C.O., HOROWITZ, I.R., ICENOGLE, J.P. and REEVES, W.C., Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J. infect. Dis., 172, 1184-1190 (1995).
27. WAGATSUMA, M., HASHIMOTO, K. and MATSUKURA, T., Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J. Virol., 64, 813-821 (1990).